PubRank

J H Falkenburg

Author PubWeight™ 85.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996 2.63
2 Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002 2.05
3 Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci U S A 1997 1.63
4 In vivo production of interleukin-5, granulocyte-macrophage colony-stimulating factor, macrophages colony-stimulating factor, and interleukin-6 during intravenous administration of high-dose interleukin-2 in cancer patients. Blood 1991 1.55
5 Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells 1991 1.50
6 HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant Registry. Leukemia 2000 1.49
7 Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med 1999 1.47
8 Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemia. Ann Hematol 1991 1.39
9 UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood 2000 1.38
10 Interleukin-1 (22-K factor) induces release of granulocyte-macrophage colony-stimulating activity from human mononuclear phagocytes. Blood 1986 1.28
11 DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood 2000 1.26
12 Simultaneous production of interleukin 6, interferon-beta and colony-stimulating activity by fibroblasts after viral and bacterial infection. Eur J Immunol 1989 1.16
13 Factors influencing release of granulocyte-macrophage colony-stimulating activity from human mononuclear phagocytes. Eur J Haematol 1988 1.15
14 Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. J Exp Med 1992 1.15
15 Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor. Blood 1988 1.13
16 Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc Natl Acad Sci U S A 2001 1.11
17 Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood 1994 1.08
18 Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells. J Clin Invest 1988 1.05
19 Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity. Blood 1995 1.03
20 Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells. J Exp Med 1988 1.03
21 Apoptin, a protein encoded by chicken anemia virus, induces cell death in various human hematologic malignant cells in vitro. Leukemia 1995 1.00
22 Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. Br J Haematol 1986 1.00
23 Similar repopulating capacity of mitotically active and resting umbilical cord blood CD34(+) cells in NOD/SCID mice. Blood 2000 0.97
24 Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16). Leukemia 1997 0.97
25 Cytokine production by the bladder carcinoma cell line 5637: rapid analysis of mRNA expression levels using a cDNA-PCR procedure. Lymphokine Cytokine Res 1991 0.96
26 Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice. Exp Hematol 2001 0.95
27 Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells. J Exp Med 1991 0.95
28 Interleukin 1 and poly(rI).poly(rC) induce production of granulocyte CSF, macrophage CSF, and granulocyte-macrophage CSF by human endothelial cells. Exp Hematol 1989 0.94
29 Regulation of myelopoiesis by murine fibroblastic and adipogenic cell lines. Exp Hematol 1993 0.93
30 Polymorphic and monomorphic HLA-DR determinants on human hematopoietic progenitor cells. Blood 1984 0.92
31 Human erythroid progenitor cells express Rhesus antigens. Blood 1985 0.92
32 T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation. Proc Natl Acad Sci U S A 1998 0.92
33 Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation. Bone Marrow Transplant 1995 0.91
34 Human hematopoietic progenitor cells in long-term cultures express HLA-DR antigens and lack HLA-DQ antigens. J Exp Med 1985 0.91
35 Human fibroblasts produce granulocyte-CSF, macrophage-CSF, and granulocyte-macrophage-CSF following stimulation by interleukin-1 and poly(rI).poly(rC). Blood 1988 0.91
36 Sustained engraftment of mice transplanted with IL-1-primed blood-derived stem cells. J Immunol 1992 0.91
37 Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact. Blood 1993 0.89
38 Proliferation of myeloid progenitor cells in human long-term bone marrow cultures is stimulated by interleukin-1 beta. Blood 1988 0.88
39 Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood 1996 0.88
40 Comparison of repopulating ability of hematopoietic progenitor cells isolated from human umbilical cord blood or bone marrow cells in NOD/SCID mice. Bone Marrow Transplant 1998 0.86
41 Removal of neoplastic cells from autologous bone marrow grafts with monoclonal antibodies. Semin Hematol 1984 0.86
42 Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes. J Clin Invest 1995 0.86
43 Interleukin 1 as a cytokine inducer. Immunobiology 1986 0.84
44 Biology and treatment of myelodysplastic syndromes--developments in the past decade. Ann Hematol 1993 0.83
45 Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients. Bone Marrow Transplant 1992 0.83
46 Complement-dependent cytotoxicity in the analysis of antigenic determinants on human hematopoietic progenitor cells with HLA-DR as a model. Exp Hematol 1984 0.83
47 In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation. Bone Marrow Transplant 1992 0.83
48 Expression and induction of costimulatory and adhesion molecules on acute myeloid leukemic cells: implications for adoptive immunotherapy. Exp Hematol 2000 0.83
49 Constitutive in vivo cytokine and hematopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals. Blood 1995 0.83
50 Colony growth of normal and neoplastic cells in various concentrations of methylcellulose. Exp Hematol 1988 0.83
51 HLA class II restricted T-cell reactivity to a developmentally regulated antigen shared by leukemic cells and CD34+ early progenitor cells. Blood 1997 0.83
52 Influence of IL-1 alpha and -1 beta on the survival of human bone marrow cells responding to hematopoietic colony-stimulating factors. J Immunol 1989 0.82
53 Cell-mediated lysis of human hematopoietic progenitor cells. Leukemia 1987 0.82
54 Association of stress during delivery with increased numbers of nucleated cells and hematopoietic progenitor cells in umbilical cord blood. Am J Obstet Gynecol 2000 0.82
55 Effect of myogenic and adipogenic differentiation on expression of colony-stimulating factor genes. Mol Cell Biol 1990 0.82
56 The hematopoietic activities of interleukin-1. Biotherapy 1989 0.82
57 Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sources. Bone Marrow Transplant 2001 0.81
58 Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells. Hum Immunol 1997 0.81
59 Regulatory effects of T cell lymphokines on cytokine gene expression in monocytes. Lymphokine Cytokine Res 1993 0.81
60 Influence of delivery on numbers of leukocytes, leukocyte subpopulations, and hematopoietic progenitor cells in human umbilical cord blood. Blood Cells 1994 0.81
61 Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon. Biol Blood Marrow Transplant 1996 0.81
62 HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMT. Blood 1999 0.80
63 Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome. Bone Marrow Transplant 2001 0.80
64 Impaired expression of CD28 on T cells in hairy cell leukemia. Clin Immunol 1999 0.80
65 Interleukin-6 is not involved in the interleukin-1-induced production of colony-stimulating factors by human bone marrow stromal cells and fibroblasts. Blood 1989 0.80
66 Proliferation and cytogenetic analysis of hairy cell leukemia upon stimulation via the CD40 antigen. Blood 1994 0.80
67 Human cytotoxic CD8+ T-lymphocyte clones engraft in severe combined immunodeficient (SCID) mice but show diminished function. J Immunother 1997 0.80
68 Unconventional rapid Erk1,2 activation is indispensable for proliferation of the growth factor-independent myeloid leukemic cell line KG1. Leukemia 1998 0.79
69 Influence of T-lymphocytes and lactoferrin on the survival-promoting effects of IL-1 and IL-6 on human bone marrow granulocyte-macrophage and erythroid progenitor cells. Exp Hematol 1991 0.79
70 The biological activities of interleukin-1. Blut 1989 0.79
71 Colony growth of human hematopoietic progenitor cells in the absence of serum is supported by a proteinase inhibitor identified as antileukoproteinase. J Exp Med 1996 0.79
72 High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma. Ann Hematol 1995 0.79
73 Hairy cell leukemia-specific recognition by multiple autologous HLA-DQ or DP-restricted T-cell clones. Blood 1999 0.78
74 Blood component therapy in bone marrow transplantation. Semin Hematol 1984 0.78
75 Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation. Hum Immunol 1993 0.78
76 Aplastic anaemia in donor cells 14 years after bone-marrow transplant. Lancet 1999 0.78
77 Homing and antigenic characterization of a human non-Hodgkin's lymphoma B cell line in severe combined immunodeficient (SCID) mice. Leukemia 1994 0.78
78 IL-4 down-regulates IL-2-, IL-3-, and GM-CSF-induced cytokine gene expression in peripheral blood monocytes. Ann Hematol 1994 0.78
79 Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells. Blood 1992 0.78
80 Interleukin-1 synergizes with granulocyte-macrophage colony-stimulating factor on granulocytic colony formation by intermediate production of granulocyte colony-stimulating factor. Blood 1989 0.78
81 T-cell dysfunction in hairy cell leukemia: an updated review. Leuk Lymphoma 1998 0.77
82 Expression of CD11, CDw15, and transferrin receptor antigens on human hematopoietic progenitor cells. Exp Hematol 1986 0.77
83 8-Bromo-cAMP induces a proliferative response in an IL-3 dependent leukemic cell line and activates Erk 1,2 via a Shc-independent pathway. Biochim Biophys Acta 1997 0.77
84 HLA-class II disparity is necessary for effective T cell mediated Graft-versus-Leukemia effects in NOD/scid mice engrafted with human acute lymphoblastic leukemia. Leukemia 2012 0.77
85 Selective response of CD5+ B cell malignancies to activation of the CD72 antigen. Clin Immunol Immunopathol 1998 0.76
86 Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice. Exp Hematol 1996 0.76
87 Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis. Br J Haematol 2001 0.76
88 Recovery of hematopoiesis after blood-group-incompatible bone marrow transplantation with red-blood-cell-depleted grafts. Transplantation 1985 0.76
89 A single low dose of human recombinant interleukin 1 accelerates the recovery of neutrophils in mice with cyclophosphamide-induced neutropenia. Exp Hematol 1989 0.75
90 The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses. Hum Immunol 2000 0.75
91 Abnormally activated T lymphocytes in the spleen of patients with hairy-cell leukemia. Leukemia 1994 0.75
92 Extramedullary hematopoietic growth factor and cytokine gene expression indicate endocrine regulation of hematopoiesis in patients with acute appendicitis. Ann Hematol 1998 0.75
93 Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes. J Immunol 1989 0.75
94 Unrelated bone marrow transplantation as a rescue procedure following inadvertent loss of an autologous bone marrow graft. Bone Marrow Transplant 1996 0.75
95 Human interleukin for DA cells (HILDA) does not affect the proliferation and differentiation of hematopoietic progenitor cells in human long-term bone marrow cultures. Exp Hematol 1992 0.75
96 Umbilical cord blood banking in The Netherlands. Bone Marrow Transplant 1998 0.75
97 Interleukin-9 stimulates the proliferation of enriched human erythroid progenitor cells: additive effect with GM-CSF. Ann Hematol 1993 0.75
98 Specific T cell therapy in leukemia. J Hematother Stem Cell Res 2001 0.75
99 The role of cytokines and hematopoietic growth factors in the autocrine/paracrine regulation of inducible hematopoiesis. Ann Hematol 1997 0.75
100 Interleukin-10, interleukin-12, and tumor necrosis factor-alpha differentially influence the proliferation of human CD8+ and CD4+ T-cell clones. Ann Hematol 1996 0.75
101 Removal of red cells in ABO-incompatible bone marrow transplantation. Lancet 1983 0.75
102 TCR gamma delta+ cells expressing Vgamma 9V delta2, which normally predominate the blood, are found in the spleens of patients with hairy cell leukemia. Leukemia 1997 0.75
103 Haematopoietic growth factors. Neth J Med 1989 0.75
104 Regulation of hematopoiesis by interleukin-1. Biotherapy 1990 0.75
105 Correction of abnormal T-cell receptor repertoire during interferon-alpha therapy in patients with hairy cell leukemia. Blood 1998 0.75
106 Generation of leukemia-reactive cytotoxic T lymphocytes from HLA-identical donors of patients with chronic myeloid leukemia using modifications of a limiting dilution assay. Bone Marrow Transplant 1998 0.75
107 Engraftment potential into NOD/SCID mice of CD34+ cells derived from human fetal liver as compared to fetal bone marrow. Haematologica 2001 0.75
108 Increased numbers of circulating haematopoietic progenitor cells after treatment with high-dose interleukin-2 in cancer patients. Br J Haematol 1990 0.75
109 Fetal hematopoiesis during first and second trimester of pregnancy: relevance for in utero stem cell transplantation. Ernst Schering Res Found Workshop 2001 0.75
110 Selective removal of clonogenic neoplastic B cells from human bone marrow using anti-HLA-DQ antibodies and complement. Exp Hematol 1986 0.75
111 Characterization of a novel malignant B cell line with t(14;18) and t(4;11) established from a patient with acute monoblastic leukemia. Exp Hematol 1997 0.75